Soluble ST2 for Prediction of Clinical Outcomes in Patients with ST-Segment Elevation Myocardial Infarction Receiving Primary PCI-Reference-Cited by-同舟云学术

Soluble ST2 for Prediction of Clinical Outcomes in Patients with ST-Segment Elevation Myocardial Infarction Receiving Primary PCI

Published:2019-01-31 Issue:1 Volume:60 Page:19-26
ISSN:1349-2365
Container-title:International Heart Journal
language:en
Short-container-title:Int. Heart J.

Author:

Liu Xintian¹,Hu Yuanping²³,Huang Weiping¹,Zhang Gangcheng⁴,Cao Shuzheng³,Yan Xinsheng³,Li Ling³,Zhang Litao³,Zheng Xuan²³

Affiliation:

1. Department of Cardiology, Wuhan Asia Heart Hospital, Wuhan University

2. Laboratory of Molecular Cardiology, Wuhan Asia Heart Hospital, Wuhan University

3. Department of Pathology and Clinical Laboratory, Wuhan Asia Heart Hospital, Wuhan University

4. Department of Cardiac Surgery, Wuhan Asia Heart Hospital, Wuhan University

Publisher

International Heart Journal (Japanese Heart Journal)

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/ihj/60/1/60_18-020/_pdf

Reference23 articles.

1. 1. Zhang K, Zhang XC, Mi YH, et al. Predicting value of serum soluble ST2 and interleukin-33 for risk stratification and prognosis in patients with acute myocardial infarction. Chin Med J (Engl) 2013; 126: 3628-31.

2. 2. Chen C, Qu X, Gao Z, et al. Soluble ST2 in patients with nonvalvular atrial fibrillation and prediction of heart failure. Int Heart J 2018; 59: 58-63.

3. 3. Xu SD, Su GH, Lu YX, et al. Elevated soluble ST2 and depression increased the risk of all-cause mortality and hospitalization in patients with heart failure. Int Heart J 2014; 55: 445-50.

4. 4. Jenkins WS, Roger VL, Jaffe AS, et al. Prognostic value of soluble ST2 after myocardial infarction: A community perspective. Am J Med 2017; 130: 1112.e9-1112.e15.

5. 5. American College of Emergency Physicians; Society for Cardiovascular Angiography and Interventions, O'Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013; 61: e78-e140.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Soluble tumorigenicity suppression protein (sST2) as a possible biomarker in patients with acute coronary syndrome;South Russian Journal of Therapeutic Practice;2023-06-09

2. Emerging Biomarkers for Predicting Clinical Outcomes in Patients with Heart Disease;Life;2023-01-13

3. Significance of sTREM-1 and sST2 combined diagnosis for sepsis detection and prognosis prediction;Open Life Sciences;2023-01-01

4. From Classic to Modern Prognostic Biomarkers in Patients with Acute Myocardial Infarction;International Journal of Molecular Sciences;2022-08-15

5. Research Progress of Soluble ST2 in Coronary Heart Disease;Advances in Clinical Medicine;2022